• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FRESENIUS KABI MIDAZOLAM 2MG/2ML; INTRODUCER, SYRINGE NEEDLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FRESENIUS KABI MIDAZOLAM 2MG/2ML; INTRODUCER, SYRINGE NEEDLE Back to Search Results
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Hypersensitivity/Allergic reaction (1907)
Event Date 04/22/2021
Event Type  Injury  
Event Description
Patient has a latex allergy and had a severe allergic reaction most likely as a result of fresenius simplist syringes of midazolam 2mg/2ml, ondansetron 4mg/2ml, and dexamethasone 4mg/1ml."after calling the".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MIDAZOLAM 2MG/2ML
Type of Device
INTRODUCER, SYRINGE NEEDLE
Manufacturer (Section D)
FRESENIUS KABI
three corporate dr.
lake zurich IL 60047
MDR Report Key13472134
MDR Text Key285252230
Report NumberMW5107227
Device Sequence Number3
Product Code KZH
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Pharmacist
Type of Report Initial
Report Date 04/22/2021
3 Devices were Involved in the Event: 1   2   3  
1 Patient was Involved in the Event
Date FDA Received02/04/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Is the Reporter a Health Professional? Yes
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age30 YR
Patient SexMale
Patient Weight70 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-